SCAI

48-mm Xience stent surprised with low restenosis at 1 year

Longer-term trial results support durable quality-of-life advantage

Randomized trial weighs in with extended follow-up

Tool could hold promise for reducing acute kidney injury risk

Group predisposed to calcification shows double digit rate within 6 months

Study outlines room for improvement

6-month follow-up with investigational device gives support for pivotal trial

SAFE-PAD study update doesn't support excess mortality risk

Registry illuminates trends in success, complications

Quality of life consistently improved across first-in-man studies

Pooled study data show no mortality, favorable clinical outcomes

Disrupt PAD III trial extends superiority over percutaneous transluminal angioplasty

Randomized trial answers questions on grip, pinch, and other hand outcomes

Document acknowledges skimpy evidence